
Will like to share with u these info from Nomura......
Nomura Equity Research maintains 'buy' on BIOSENSORS
Analyst: Lim Jit Soon, CFA

Biosensors' stent is flexible. Visual: Company
Management continues to maintain its guidance of 20-30% progress in revenues in spite of concerns about pricing pressures in China and Japan.
While growing its core business, the group is also looking to bolt on acquisitions to achieve its strategy of becoming a medical device platform company.
However this will be done judiciously to ensure value is enhanced for shareholders. Management also indicated that it will be seeking a share buyback mandate at the AGM scheduled for the end of this month.
We continue to maintain our Buy rating for Biosensors. Target price: $1.84.
 
infancybird ( Date: 09-Jul-2012 16:38) Posted:
|
My point is that, instead of engage in share manipulation, company resource should use to improve sales, not prevent share drop, real investors will come out when price is cheap...lol
junction ( Date: 09-Jul-2012 17:15) Posted:
|
Of course it helps.  It plunges less in a downturn and shoots up faster in an upturn! Shortists will think twice before shorting in case they get caught with their pants down.
overshoot ( Date: 09-Jul-2012 17:05) Posted:
|
when the share plunges, do u think share buy back can help? look at olam, SIA or even as big as japan goverment intervention of yen. It can help for a while, but market direction will continue....just tccs only....lol.
I am not surprised they again will benefit their corporate friends.  Those attending should question them.  I am voting against their resolutions, especially their renumeration.
infancybird ( Date: 09-Jul-2012 14:06) Posted:
|
Defensive strategy
On July 6, Singapore’s benchmark Straits
Times Index rose to 2,970 points, up 10% from
a 2Q2012 low of 2,698.8 points last month.
Given the ongoing macro uncertainties,
however, Nomura analyst Lim Jit Soon expects
the index to trade within 2,600-2,900 points
for the rest of the year despite the recent
easing measures. Indeed, while Nomura is
forecasting GDP growth of 2.7% for Singapore
this year, “weaker external demand coinciding
with a restructuring of the [Singapore]
economy will likely constrain the market in
2H2012,” Lim notes in a July 6 Singapore
strategy report.
To weather the volatility, Lim recommends
that investors improve equity returns with a
defensive stock-picking strategy. At $1.15
apiece -- down 14% since the start of the
year -- stent maker Biosensors International
is among Lim’s top picks. “The price pullback
presents buy opportunity as the outlook
remains resilient while pricing concerns
appear discounted,” Lim writes.
On July 6, Singapore’s benchmark Straits
Times Index rose to 2,970 points, up 10% from
a 2Q2012 low of 2,698.8 points last month.
Given the ongoing macro uncertainties,
however, Nomura analyst Lim Jit Soon expects
the index to trade within 2,600-2,900 points
for the rest of the year despite the recent
easing measures. Indeed, while Nomura is
forecasting GDP growth of 2.7% for Singapore
this year, “weaker external demand coinciding
with a restructuring of the [Singapore]
economy will likely constrain the market in
2H2012,” Lim notes in a July 6 Singapore
strategy report.
To weather the volatility, Lim recommends
that investors improve equity returns with a
defensive stock-picking strategy. At $1.15
apiece -- down 14% since the start of the
year -- stent maker Biosensors International
is among Lim’s top picks. “The price pullback
presents buy opportunity as the outlook
remains resilient while pricing concerns
appear discounted,” Lim writes.
gbleng ( Date: 09-Jul-2012 13:10) Posted:
|
What to expect when the company enlarging its share issues ?
 
YES, a mature and responsible coy must have Share buy back(SBB) mandate to combat such daylight bashing of a good stock. This is the 1st time this coy initiated SBB.  Also long-term investor must take note....the coy is enlarging their share issued( SGM on 26th JUl)  by  twice......Why?? I guess it must have acquisition in the offering, most likely to be announced on the 25th or 26th Jul together with their 1st Q result. This is why the share price is artificially pressed down to today`s level to  match their secret -internally agreed fixed price. Hope the value will go up thereafter. This acquisition must be very huge ,I guess. Lets wait for the good news.       
gbleng ( Date: 09-Jul-2012 13:10) Posted:
|
Infancybird, the company must have heard you...they are seeking approval for a share buy back mandate at the next AGM. At last they are thinking about preserving and enhancing shareholders value.
infancybird ( Date: 28-May-2012 15:38) Posted:
|
Hi traders
This is personal view. Chart Analysis on 4th July, posted to my  trading blog.
  Expect price to move higher.
 

more more! hopefully it can go back to April level at 1.3+ hehehe
Next stop 1.28??
Bagus.  Right time.
bishan22 ( Date: 05-Jul-2012 15:01) Posted:
|
Masuk today. Good luck.  

Bopanha ( Date: 05-Jul-2012 14:48) Posted:
|
Time to buy. And be quick! Lol.
ricourean ( Date: 05-Jul-2012 14:44) Posted:
|
Ok Coming. Go, GO, Go.
On Wednesday, Biosensors re-test the resistance at $1.21 and closed at $1.195 with HIGH volume of 11.4 million shares traded.
During the past 10 bars, there have been 6 white candles and 4 black candles for a net of 2 white candles.  During the past 50 bars, there have been 18 white candles and 29 black candles for a net of 11 black candles.
RSI & MACD are bullish as RSI trend upwards.
Important Resistance of Biosensors: $1.21
Immediate Support of Biosensors: $1.1
Currently prices are resisted by 50 days MA at............  READ MORE
 
 
congrats!!
gilraen ( Date: 03-Jul-2012 17:26) Posted:
|